comprehensive -WSS

comprehensive

author：comprehensive 2025-09-28 18:30:41 - browse：5

Is there a cure for allergies? Has the FDA become too flexible? And which drugs make you muscular?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. We also discuss the latest news in the life sciences, including a twist in the GLP-1 story, the cost of gene therapy, and, of course, pie.

For more on what we cover, here’s our full Summit coverage; here’s more on Medicare and GLP-1s; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Nick Jonas talks about managing diabetes along with his career

leisure time

WSS

A single Democrat is willing to weaken Medicare negotiation power

European regulators consider appeal over Amylyx ALS drug

Adopting new red light myopia treatments may be short

Massive project maps cells in human brain in unprecedented detail

A revolution in caring for preterm infants

STAT Readout: Today's biotech news includes Sana and Amylyx

leisure time

comprehensive

knowledge

How one medical school became remarkably diverse

There’s no way to know how good AI health technologies are

Anesthesiologist group: stop taking Ozempic before surgery

A single Democrat is willing to weaken Medicare negotiation power

As demand for Covid shots wanes, Moderna seeks its next success

Wellcome Trust names Røttingen as its new CEO

Supreme Court strikes down use of affirmative action

Eight reasons why you should get an updated Covid vaccine

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Top private equity targets in 2023: cardiology, clinical trials, lasers

knowledge

European regulators consider appeal over Amylyx ALS drug

What’s missing from the debate over nursing home staff minimums

Massive project maps cells in human brain in unprecedented detail

Surgery pushed Ben Carson to fame

Medicare Advantage plans can’t deny care with AI, CMS warns

AI gets buy

leisure time

hotspot

hotspot

focus